title: Modeling rotavirus strain dynamics in developed countries to understand the potential impact of vaccination on genotype distributions.
abstract: Understanding how immunity shapes the dynamics of multistrain pathogens is essential in determining the selective pressures imposed by vaccines. There is currently much interest in elucidating the strain dynamics of rotavirus to determine whether vaccination may lead to the replacement of vaccine-type strains. In developed countries, G1P[8] strains constitute the majority of rotavirus infections most years, but occasionally other genotypes dominate for reasons that are not well understood. We developed a mathematical model to examine the interaction of five common rotavirus genotypes. We explored a range of estimates for the relative strength of homotypic vs. heterotypic immunity and compared model predictions against observed genotype patterns from six countries. We then incorporated vaccination in the model to examine its impact on rotavirus incidence and the distribution of strains. Our model can explain the coexistence and cyclical pattern in the distribution of genotypes observed in most developed countries. The predicted frequency of cycling depends on the relative strength of homotypic vs. heterotypic immunity. Vaccination that provides strong protection against G1 and weaker protection against other strains will likely lead to an increase in the relative prevalence of non-G1 strains, whereas a vaccine that provides equally strong immunity against all strains may promote the continued predominance of G1. Overall, however, disease incidence is expected to be substantially reduced under both scenarios and remain below prevaccination levels despite the possible emergence of new strains. Better understanding of homotypic vs. heterotypic immunity, both natural and vaccine-induced, will be critical in predicting the impact of vaccination.
authors.affiliation: Department of Ecology and Evolutionary Biology and Woodrow Wilson School of Public and International Affairs, Princeton University, Princeton, NJ 08544, USA. vepitzer@princeton.edu
authors.forename: Virginia E
authors.initials: VE
authors.lastname: Pitzer
authors.forename: Manish M
authors.initials: MM
authors.lastname: Patel
authors.forename: Ben A
authors.initials: BA
authors.lastname: Lopman
authors.forename: Cécile
authors.initials: C
authors.lastname: Viboud
authors.forename: Umesh D
authors.initials: UD
authors.lastname: Parashar
authors.forename: Bryan T
authors.initials: BT
authors.lastname: Grenfell
mesh_terms: D019049:Developed Countries; D005838:Genotype; D006801:Humans; D018448:Models, Immunological; D011157:Population Dynamics; D012401:Rotavirus / Q000187:drug effects / Q000235:genetics*; D012400:Rotavirus Infections / Q000235:genetics / Q000635:transmission*; D012641:Selection, Genetic; D013045:Species Specificity; D014611:Vaccination; D014765:Viral Vaccines / Q000494:pharmacology*
chemical_list: D014765:Viral Vaccines
references.citation: Nature. 2003 Mar 27;422(6930):428-33
references.pmid: 12660783
references.citation: J Infect Dis. 1990 Apr;161(4):667-79
references.pmid: 2156942
references.citation: J Med Virol. 2009 Mar;81(3):568-71
references.pmid: 19152398
references.citation: J Infect Dis. 2009 Nov 1;200 Suppl 1:S222-7
references.pmid: 19821713
references.citation: Vaccine. 2010 Apr 19;28(18):3118-26
references.pmid: 20197142
references.citation: Epidemiol Infect. 2005 Apr;133(2):279-89
references.pmid: 15816153
references.citation: Lancet. 2006 Jul 22;368(9532):323-32
references.pmid: 16860702
references.citation: Proc Biol Sci. 2009 Jul 22;276(1667):2541-8
references.pmid: 19369266
references.citation: J Med Virol. 1995 Dec;47(4):404-9
references.pmid: 8636710
references.citation: Pediatr Infect Dis J. 2011 Jan;30(1 Suppl):S42-7
references.pmid: 21183839
references.citation: Commun Dis Intell Q Rep. 2010 Dec;34(4):427-34
references.pmid: 21413527
references.citation: Vaccine. 2010 Nov 23;28(50):7923-32
references.pmid: 20933563
references.citation: Pediatr Infect Dis J. 2011 Jan;30(1 Suppl):S48-53
references.pmid: 21183840
references.citation: Proc Natl Acad Sci U S A. 2002 Dec 24;99(26):17209-14
references.pmid: 12481034
references.citation: Proc Natl Acad Sci U S A. 2008 Feb 12;105(6):2238-43
references.pmid: 18250338
references.citation: J Diarrhoeal Dis Res. 1996 Sep;14(3):194-200
references.pmid: 9019014
references.citation: Science. 2006 Dec 22;314(5807):1898-903
references.pmid: 17185596
references.citation: Science. 2004 Jul 16;305(5682):371-6
references.pmid: 15218094
references.citation: J Clin Microbiol. 2004 Apr;42(4):1434-8
references.pmid: 15070985
references.citation: Rev Med Virol. 2005 Jan-Feb;15(1):29-56
references.pmid: 15484186
references.citation: Science. 2009 Jul 17;325(5938):290-4
references.pmid: 19608910
references.citation: Science. 2009 Jun 19;324(5934):1557-61
references.pmid: 19433588
references.citation: J Med Virol. 2004 Feb;72(2):320-7
references.pmid: 14695677
references.citation: Vaccine. 2009 Nov 20;27 Suppl 5:F93-6
references.pmid: 19931729
references.citation: Curr Opin Infect Dis. 2011 Oct;24(5):442-50
references.pmid: 21799408
references.citation: Pediatr Infect Dis J. 2009 Mar;28(3 Suppl):S57-9
references.pmid: 19252425
references.citation: Proc Natl Acad Sci U S A. 1999 Jan 19;96(2):790-4
references.pmid: 9892712
references.citation: J Infect Dis. 2009 Nov 1;200 Suppl 1:S99-S105
references.pmid: 19817622
references.citation: Proc Biol Sci. 1994 Jun 22;256(1347):231-8
references.pmid: 7914705
references.citation: Science. 2004 Jan 16;303(5656):327-32
references.pmid: 14726583
references.citation: Philos Trans R Soc Lond B Biol Sci. 2003 Oct 29;358(1438):1625-41
references.pmid: 14561323
references.citation: J R Soc Interface. 2008 Jan 6;5(18):3-13
references.pmid: 17459810
references.citation: Gastroenterology. 2009 Dec;137(6):1970-5
references.pmid: 19632228
references.citation: Vaccine. 2009 Nov 20;27 Suppl 5:F102-7
references.pmid: 19931706
references.citation: Epidemiol Infect. 2010 Jun;138(6):884-97
references.pmid: 20028612
references.citation: J R Soc Interface. 2007 Feb 22;4(12):137-42
references.pmid: 17015285
references.citation: PLoS Pathog. 2009 Oct;5(10):e1000634
references.pmid: 19851457
references.citation: J Math Biol. 1989;27(3):233-58
references.pmid: 2746140
references.citation: Proc Natl Acad Sci U S A. 2005 Oct 18;102(42):15259-64
references.pmid: 16217017
references.citation: Future Microbiol. 2009 Dec;4(10):1303-16
references.pmid: 19995190
references.citation: Science. 1998 May 8;280(5365):912-5
references.pmid: 9572737
references.citation: J Infect Dis. 1990 Oct;162(4):810-6
references.pmid: 2169496
references.citation: Pediatr Infect Dis J. 2011 Jan;30(1 Suppl):S35-41
references.pmid: 21048523
references.citation: J Math Biol. 1997 Aug;35(7):825-42
references.pmid: 9269738
references.citation: Proc Biol Sci. 2006 Nov 22;273(1603):2879-86
references.pmid: 17015366
references.citation: N Engl J Med. 2011 Jul 28;365(4):337-46
references.pmid: 21793745
references.citation: J Infect Dis. 1998 Dec;178(6):1562-6
references.pmid: 9815204
references.citation: Vaccine. 2009 Jun 19;27(30):4025-30
references.pmid: 19389452
references.citation: Proc Natl Acad Sci U S A. 2006 Sep 19;103(38):14234-9
references.pmid: 16966609
references.citation: Proc Natl Acad Sci U S A. 2006 Aug 1;103(31):11802-7
references.pmid: 16868086
references.citation: J Virol. 2006 Nov;80(21):10724-33
references.pmid: 16928744
references.citation: Am J Epidemiol. 1989 Nov;130(5):981-8
references.pmid: 2816905
references.citation: Math Biosci. 1999 Nov-Dec;162(1-2):33-51
references.pmid: 10616279
references.citation: Eur J Clin Microbiol Infect Dis. 2010 Aug;29(8):955-60
references.pmid: 20490883
references.citation: Emerg Infect Dis. 2009 Jan;15(1):95-7
references.pmid: 19116062
references.citation: N Engl J Med. 1996 Oct 3;335(14):1022-8
references.pmid: 8793926